146 related articles for article (PubMed ID: 8886621)
21. Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline.
Nakane M; Takahashi S; Sekine I; Fukui I; Koizumi M; Kage K; Ito Y; Aiba K; Horikoshi N; Hatake K; Ishikawa Y; Ogata E
Ann Oncol; 2003 Sep; 14(9):1449-51. PubMed ID: 12954587
[No Abstract] [Full Text] [Related]
22. Three cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine, and dacarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercatecholaminemia.
Tada K; Okuda Y; Yamashita K
Horm Res; 1998; 49(6):295-7. PubMed ID: 9623522
[TBL] [Abstract][Full Text] [Related]
23. Clinical review: Current treatment of malignant pheochromocytoma.
Scholz T; Eisenhofer G; Pacak K; Dralle H; Lehnert H
J Clin Endocrinol Metab; 2007 Apr; 92(4):1217-25. PubMed ID: 17284633
[TBL] [Abstract][Full Text] [Related]
24. [Case of malignant pheochromocytoma with successful control of systemic metastasis with CVD chemotherapy].
Minami T; Doi Y; Tetsuo H; Baba K; Seto S; Suzuki S; Hayano M; Yano S; Minami K; Oshibuchi E
Nihon Naika Gakkai Zasshi; 1996 Dec; 85(12):2078-80. PubMed ID: 9036176
[No Abstract] [Full Text] [Related]
25. [Clinical course of patient with malignant pheochromocytoma who was treated with CVD chemotherapy and alpha-methyl-p-tyrosine].
Nagata M; Takayama T; Nishijima N; Mugiya S; Ushiyama T; Ozono S
Nihon Hinyokika Gakkai Zasshi; 2010 May; 101(4):615-8. PubMed ID: 20535990
[TBL] [Abstract][Full Text] [Related]
26. [A case of extra-adrenal pheochromocytoma presenting with lung metastasis].
Uemura M; Nakagawa M; Mukai M; Kanno N; Nishimura K; Miyoshi S; Yoshida K; Kawano K
Hinyokika Kiyo; 2004 Jan; 50(1):29-32. PubMed ID: 15032012
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic strategy for pheochromocytoma].
Iihara M
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1623-6. PubMed ID: 19838020
[TBL] [Abstract][Full Text] [Related]
28. Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy.
Sisson JC; Shapiro B; Shulkin BL; Urba S; Zempel S; Spaulding S
Am J Clin Oncol; 1999 Aug; 22(4):364-70. PubMed ID: 10440191
[TBL] [Abstract][Full Text] [Related]
29. [Malignant pheochromocytoma].
Tanabe A; Tsuiki M; Takano K; Naruse M
Nihon Rinsho; 2006 May; Suppl 1():739-43. PubMed ID: 16776263
[No Abstract] [Full Text] [Related]
30. [A Case of Synchronous Malignant Pheochromocytomas in Bilateral Adrenal Glands].
Usui K; Hirasawa T; Kobayashi M; Shioi K; Kobayashi K; Sakai N; Noguchi S; Tsuura Y
Hinyokika Kiyo; 2016 Jun; 62(6):307-12. PubMed ID: 27452493
[TBL] [Abstract][Full Text] [Related]
31. High-voltage irradiation and combination chemotherapy for malignant pheochromocytoma.
Siddiqui MZ; Von Eyben FE; Spanos G
Cancer; 1988 Aug; 62(4):686-90. PubMed ID: 3135110
[TBL] [Abstract][Full Text] [Related]
32. Sunitinib, a novel therapy for anthracycline- and cisplatin-refractory malignant pheochromocytoma.
Park KS; Lee JL; Ahn H; Koh JM; Park I; Choi JS; Kim YR; Park TS; Ahn JH; Lee DH; Kim TW; Lee JS
Jpn J Clin Oncol; 2009 May; 39(5):327-31. PubMed ID: 19264767
[TBL] [Abstract][Full Text] [Related]
33. Palliative chemotherapy for malignant pheochromocytoma: symptomatic palliation of two cases.
Iwabuchi M; Oki Y; Nakamura H
Intern Med; 1999 May; 38(5):433-5. PubMed ID: 10397082
[TBL] [Abstract][Full Text] [Related]
34. [Malignant pheochromocytoma presenting as an acute abdomen: a case report].
Kobayashi M; Katoh T; Sawada N; Sahashi M; Miyake K
Hinyokika Kiyo; 1990 Jul; 36(7):813-7. PubMed ID: 2239578
[TBL] [Abstract][Full Text] [Related]
35. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experience.
Deutschbein T; Matuszczyk A; Moeller LC; Unger N; Yuece A; Lahner H; Mann K; Petersenn S
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):540-3. PubMed ID: 21667440
[TBL] [Abstract][Full Text] [Related]
36. [Therapy of malignant pheochromocytoma. Invitation to participate in a randomized multicenter study].
Mundschenk J; Kopf D; Lehnert H
Dtsch Med Wochenschr; 1998 Jan; 123(1-2):32-3. PubMed ID: 9465855
[No Abstract] [Full Text] [Related]
37.
Fishbein L; Ben-Maimon S; Keefe S; Cengel K; Pryma DA; Loaiza-Bonilla A; Fraker DL; Nathanson KL; Cohen DL
Endocr Relat Cancer; 2017 Aug; 24(8):L51-L55. PubMed ID: 28566531
[No Abstract] [Full Text] [Related]
38. Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial.
Hempling RE; Piver MS; Baker TR
Am J Clin Oncol; 1995 Aug; 18(4):282-6. PubMed ID: 7625366
[TBL] [Abstract][Full Text] [Related]
39. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine.
Wu LT; Averbuch SD; Ball DW; de Bustros A; Baylin SB; McGuire WP
Cancer; 1994 Jan; 73(2):432-6. PubMed ID: 8293411
[TBL] [Abstract][Full Text] [Related]
40. Clinical management of malignant adrenal tumors.
Kopf D; Goretzki PE; Lehnert H
J Cancer Res Clin Oncol; 2001; 127(3):143-55. PubMed ID: 11260859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
